Seize the day and think of a recession as the best time to pass competitors, says Bain & Co.
Sales of the company's diabetes division fell 1% in the first quarter amid a supply shortfall for its glucose monitor sensors.
The deal will expand Cardinal's medical products business but its shares dropped 11.5% on updated guidance for fiscal 2017.
The deal gives Medtronic access to a market for a heart failure treatment that is expected to grow in the mid-to-high single digits through 2017.
A U.S. Tax Court judge says the IRS' allocation of profits between the medical device maker's operations in the U.S. and Puerto Rico was unreasonable.
Karen Parkhill, one of American Banker's Most Powerful Women in Banking, takes over as finance chief of the medical device maker.
Mobile health apps are becoming more capable and potentially rather useful.
The transaction is the medical device maker's largest this year.
Will fewer companies flee the United States if the statutory tax rate is lowered? Not necessarily, finds a Reuters analysis.
The question of whether companies are legitimately trying to reduce taxes or trying to cheat the government of corporate tax has stirred a global debate.
The President doesn't need Congress' help to thwart tax inversions, ex-Treasury official says.
Is there a way to improve the path to better business processes?
